After loss of the von Hippel–Lindau (VHL) gene, which is insufficient to drive ccRCC on its own [1], the genetic landscape of ccRCC is dominated by mutations in epigenetic regulators SETD2, polybromo 1 (PBRM1), and BAP1. The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.